Categories: News

Neoss® Group launches NeoTell™ a new device to measure implant stability.

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

ZÜRICH, Sept. 14, 2023 /PRNewswire/ — Earlier this year, Neoss Group, a pioneer in dental implant solutions, announced a partnership with Osstell AB, a global leader in implant stability measurement and osseointegration progress monitoring. Today, we proudly introduce the first fruit of this collaboration: NeoTell, an affordable, rapid, and precise device designed to measure implant stability. NeoTell equips clinicians with the tools they need to assess implant stability swiftly and accurately, thereby improving patient outcomes and simplifying the digital workflow.

NeoTell will offer clinicians the means to work more efficiently and effectively

“NeoTell will offer clinicians the means to work more efficiently and effectively. Our collaboration with Osstell ensures that we can provide the dental community with a comprehensive solution that enhances the predictability and success of dental implant procedures. We believe that NeoTell will become an indispensable tool for dental professionals.” – Dr. Robert Gottlander, President and CEO of the Neoss Group.

NeoTell empowers dental professionals with an intuitive and user-friendly device that delivers objective results without invasive procedures. With this proven technology, clinicians can make informed treatment decisions swiftly and confidently.

One of the key advantages of NeoTell is its affordability, making RFA (Resonance Frequency Analysis) technology accessible to a wide range of dental practitioners. This affordability ensures that more clinicians can leverage the benefits of RFA technology. Patients can also anticipate improved outcomes, as this technology enables more precise assessment and treatment planning, ultimately leading to greater confidence and satisfaction in their dental implant procedures.

To learn more about the NeoTell, please visit https://neoss.com/neotell.

About Neoss®

Neoss was founded with a vision to enhance dental implant treatments for both clinicians and patients. With our extensive expertise in dental implant procedures, we are committed to develop user-friendly and cost-effective solutions that enhance the efficiency of dental professionals and improve patient outcomes. Our products and solutions are designed, researched, and developed in Gothenburg, Sweden – the birthplace of Osseointegration and the renowned pioneer, Professor Per-Ingvar Brånemark. You can have confidence knowing that our offerings are supported by scientific research and long-term clinical results, providing you and your patients with peace of mind. To find out more visit https://neoss.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/neoss-group-launches-neotell-a-new-device-to-measure-implant-stability-301926948.html

SOURCE Neoss

Staff

Recent Posts

Glassbeam Awarded FedRAMP Authorization for its SAAS analytics solution for connected medical systems by the U.S. Department of Veterans Affairs.

This designation enables Glassbeam to support federal government agency customers increase uptime for all MRI…

1 hour ago

XtalPi Announces Strategic Acquisition of Liverpool ChiroChem (LCC), Unlocking Unprecedented Power in Chemical Space Exploration

CAMBRIDGE, Mass. and LIVERPOOL, United Kingdom, June 13, 2025 /PRNewswire/ -- XtalPi, a leading life…

1 hour ago

Mitsubishi Research Institute and Astellas Announce Collaboration to Support Pharma Startups in Japan

Accelerating the Growth of Globally Active Drug-Discovery Startups from Japan TOKYO, June 13, 2025 /PRNewswire/…

1 hour ago

Maria Ansari, MD, FACC, named to Modern Healthcare’s list of 50 Most Influential Clinical Executives

Co-CEO of The Permanente Federation and leader of multiple Permanente Medical Groups at Kaiser Permanente,…

13 hours ago

Dignify Therapeutics Announces Jeff Welch as Chief Operating Officer

RESEARCH TRIANGLE PARK, N.C., June 12, 2025 /PRNewswire/ -- Dignify Therapeutics (Dignify), a pharmaceutical and medical…

13 hours ago

Transforming Communication in the Workplace and Beyond: Glodean Champion Launches “The Process to LOVE™” – A Revolutionary Communication Framework for Human-Centered Leadership

CHICAGO, June 12, 2025 /PRNewswire/ -- Workplace miscommunication costs businesses an estimated $1.2 trillion annually and…

13 hours ago